Web Analytics

3 Latest Announced Rounds

$2,265.93M Raised in 95 Funding Rounds in the past 7 Days - View All

Funding Round Profile

RS Research

start up
Turkey - Istanbul, Pendik
  • 15/12/2021
  • Series A
  • $12,000,000

RS Research is a clinical stage biotechnology start-up discovering and developing smart nanomedicines. based on innovative drug delivery platform Sagitta® for targeted chemotherapy. Bringing together the powers of science and industry, we have developed a drug delivery technology that will help patients fighting against cancer with superior therapeutic index, “a Cure With a Smile”. Our proprietary drug delivery platform SagittaTM allows designing targeted drug candidates for different indications, which yields into development of our current own portfolio as well as an outstanding co-development potential.


Related People

Sena NomakCo Founder

Sena Nomak Turkey - Istanbul

Creative thinker and strategy engineer with a focus on Corporate Development, Investor Relations, Operations & Technology Strategy, and Portfolio Management.

After working 10 years in shipbuilding and defense industries, Sena started his start-up career in 2011 as a co-founder of an engineering company. As a serial entrepreneur, Sena continues conducting international projects in different industries, transferring his know-how to bring out the best results and success stories with a multidisciplinary approach. Sena utilizes his extensive skills of business development, innovative thinking, R&D, strategy making and network building for the good of other entrepreneurs through coaching and mentoring, as well as his own businesses. Sena has founded and managed multiple teams showing proactive, empathic and creative leadership. His talent management skills also reflect to business partnerships he builds in different industries through projects he leads in a strategic roadmap manner, where he contributes to capacity building and co-creation abilities, which can help networks become ecosystems. Sena considers his current efforts for mentoring numerous start-ups as a responsibility to “pay it forward” to the ecosystem. With start-ups being the locomotive in the new era of collaboration between stakeholders, they are the keys to unlock the future of innovation.

Since 2015, Sena is the Co-Founder & COO of RS Research, a clinical-stage biotechnology start-up developing nanomedicines based on innovative drug delivery platform Sagitta® for targeted chemotherapy. He founded RS Research together with Prof. Rana Sanyal to take the necessary steps for bringing cutting-edge therapies based on its disruptive technology for patients who are fighting cancer. With his previous experiences in starting and managing small business, fundraising, as well as grant submissions and tax issues, Sena is responsible for all administrative, operational and financial processes.

Sena has BEng and MEng degrees from Istanbul Technical University Marine Engineering Department, and he is currently working toward his PhD. He speaks English and Turkish fluently. Sena, no longer a professional at sea, challenging the waves to safely berth a colossal ship, but is an amateur enjoying the sail in harmony with the wind and the water.